You are here

Article Text

Article menu
Download PDFPDF
Research letter
HIV postexposure prophylaxis during the COVID-19 pandemic: experience from Madrid
  1. Javier Sánchez-Rubio1,
  2. Manuel Vélez-Díaz-Pallarés2,
  3. Carmen Rodríguez González3,
  4. Patricia Sanmartin Fenollera4,
  5. Cristina García Yubero5,
  6. María Fernández-Pacheco García-Valdecasas6
  1. 1 Pharmacy, Hospital Universitario de Getafe, Getafe, Madrid, Spain
  2. 2 Pharmacy, Hospital Universitario Ramon y Cajal, Madrid, Spain
  3. 3 Pharmacy, Hospital General Universitario Gregorio Marañón, Madrid, Spain
  4. 4 Pharmacy, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain
  5. 5 Pharmacy, Hospital Universitario Infanta Sofía, San Sebastian de los Reyes, Madrid, Spain
  6. 6 Pharmacy, Hospital Universitario Príncipe de Asturias, Alcala de Henares, Madrid, Spain
  1. Correspondence to Dr Javier Sánchez-Rubio, Pharmacy, Hospital Universitario de Getafe, 28905 Getafe, Spain; javier.sanchez{at}salud.madrid.org

https://doi.org/10.1136/sextrans-2020-054680

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Antiretroviral prophylaxis started within 72 hours of a possible exposure is a feasible and cost-effective measure to prevent HIV infection.1 In Spain, post-exposure prophylaxis (PEP) is provided free-of-charge via a hospital-based HIV specialist. As the COVID-19 pandemic rages across the world, questions are emerging on its impact on routine healthcare. Spain imposed a national lockdown on 14 March 2020, with the strictest measures applied to the Madrid region, the epicentre of the epidemic.2 The state of emergency remained in effect through 21 …

    View Full Text

    Footnotes

    • Handling editor Anna Maria Geretti

    • Collaborators Madrid HIV Pharmaceutical Care Group: Oscar Pinar, Ana Ontañón, María Ángeles Campos, Elena García-Benayas, Concepción Martínez, Carlos Folguera, Jose Alberto Peña, Laura García, Virginia Collado, Francisco Moreno, Laura Corrales, Elena Matilla, Irene Cañamares, Elena Tortajada, Cristina Capilla.

    • Contributors Al authors have contributed to the planning, conduct and reporting of the work described in the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.